BioInvent International AB (BIX0) - Financials, balance sheet (quarterly)

3.23500 EUR

Last update Jun 25, 8:03 AM CEST

Main market

Day range

3.23500

Previous close

3.23500

Open

3.23500

Access this stock data via API

BioInvent International AB

3.24

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	862.8M	989.2M	1.1B	1.2B
Current assets	819.1M	943.2M	1.0B	1.1B
Cash	—	434.8M	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	475.3M	434.8M	717.4M	470.3M
Other short term investments	266.9M	432.3M	232.8M	591.2M
Accounts receivable	69.2M	8.3M	51.0M	48.0M
Other receivables	—	23.0M	—	—
Inventory	7.7M	11.0M	9.9M	10.5M
Prepaid assets	—	33.8M	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	43.7M	46.0M	76.5M	79.0M
Properties	43.7M	115.5M	47.4M	50.3M
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-86.0M	—	—
Goodwill	0	0	0	0
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	93.1M	103.4M	84.4M	101.5M
Current liabilities	87.0M	95.2M	76.1M	91.1M
Accounts payable	—	49.1M	—	—
Accrued expenses	—	—	—	—
Short term debt	9.2M	9.2M	8.7M	8.7M
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	77.9M	5.5M	67.4M	82.4M
Non current liabilities	6.0M	8.2M	8.3M	10.4M
Long term provisions	—	—	—	—
Long term debt	6.0M	8.2M	8.3M	10.4M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	—	13.2M	—	—
Retained earnings	—	-2.9B	—	—
Other shareholders equity	—	—	—	—
Total shareholders equity	769.7M	885.8M	1.0B	1.1B
Additional paid in capital	—	3.8B	—	—
Treasury stock	—	—	—	—
Minority interest	—	—	—	—